The Justice Department is scrutinizing UnitedHealth Group’s Medicare billing, raising concerns about potential overpayments and sparking a drop in the company’s stock.
The US Justice Department is investigating UnitedHealth Group’s Medicare billing practices, prompting a fall in the company’s stock price. The probe is part of a broader antitrust investigation into the healthcare giant.
